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The ultimate position of substituted 2-aminothiophenes in the field of drug design
and synthesis of pharmaceuticals comes from their advantageous properties. The thio-
phene ring is bioisosteric replacement for the phenyl group broadly present in active
drugs; the thiophene core exists in many natural and synthetic pharmaceuticals (1, 2). In
the present work, ethyl-2-aminothiophene-3-carboxylic was expressed as a synthone for
many new condensed heterocyclic systems viz. thieno[2,3-d]pyrimidine, thienylthiourea,
thienylacetamide, thienylcarbohydrazide. Fused and polyfunctional substituted thio-
phene play an important role, especially when linked to a pyrimidine ring; thienopyri-
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2-Amino-5-acetyl-4-methyl-thiophene-3-carboxylic acid
ethyl ester (1) and 5-acetyl-2-amino-4-methylthiophene-
-3-carbohydrazide (2) were synthesized and used as star-
ting materials for the synthesis of new series of 1-(5-
-amino-4-(3,5-dimethyl-1H-pyrazole-1-carbonyl)-3-methyl-
thiophen-2-yl) ethanone (3a), 1-(5-amino-4-(4-chloro-3,5-
-dimethyl-1H-pyrazole-1-carbonyl)-3-methylthiophen-2-
-yl) ethanone (3b), 1-(4-methyl-2-amino-5-acetylthio-
phene-3-carbonyl)pyrazolidine-3,5-dione (4), (Z)-N'-(4
-methyl-2-amino-5-acetylthiophene-3-carbonyl) formo-
hydrazonic acid (5a), (Z)-ethyl-N'-4-methyl-2-amino-5-
-acetylthiophene-3-carbonylformo hydrazonate (5b), 6-
-acetyl-3-amino-2,5-dimethylthieno[2,3-d]pyrimidin-4(3H)-
-one (8), 5-methyl-3-amino-2-mercapto-6-acetylthieno
[2,3-d]pyrimidin-4(3H)-one (10) and 5-methyl-6-acetyl-2-
-thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one (12)
as potential antioxidant and antitumor agents. Pharma-
cological tests showed that compounds 6a, 6b, 8, 10 and
12 exhibited significant antitumor and antioxidant acti-
vity.
Keywords: thienopyrazole, thieno[2,3-d]pyrimidines, thio-
phenecarbohydrazide, antioxidant activity, bleomycin-
-dependent DNA damage, antitumor activity
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midine derivatives possess pharmacological properties as A1 adenosine receptor ago-
nists (3, 4), phosphodiesterase inhibitors and many receptor antagonists (5, 6). Various
thieno [2,3-d] pyrimidine derivatives show pronounced antitumor (7) and radioprotec-
tive activities (8), acts as immunomodulators (9) and were used for prophylaxis and the-
rapy of cerebral ischemia (10), malaria (11), tuberculosis (12), Alzheimer’s disease (13),
Parkinson’s disease (14), and other diseases (15, 16). Design and synthesis of the novel
thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxi-
dant and antitumor agents were explored.
EXPERIMENTAL
All melting points were taken on an Electrothermal IA 9100 series digital melting
point apparatus (Shimadzu, Japan). Elemental analyses were performed at Vario EL
(Elementar, Germany). Microanalytical data were processed in the microanalytical cen-
ter, Faculty of Science, Cairo University. The IR spectra (KBr disk) were recorded using a
Perkin-Elmer 1650 spectrometer (USA). 1H NMR spectra were determined using Jeol 270
MHz and Jeol JMS-AX 500 MHz (Jeol, Japan) with internal standard MeSi4. Mass spectra
were recorded on an EI Ms-QP 1000 EX (Shimadzu) at 70 eV. Pharmacological evalua-
tions were done in pharmacological unit, Department of Pharmacognosy, Faculty of
Pharmacy, Mansoura University, Egypt.
DNA (calf thymus type 1), bleomycin sulfate, butylated hydroxyanisole (BHA), thio-
barbituric acid (TBA), ethylenediaminetetraacetic acid (EDTA) and ascorbic acid were
obtained from Sigma (USA). 2,2’-Azo-bis-(2-amidinopropane) dihydrochloride (AAPH),
2,2'-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS) were purchased from Wako
Co. (USA).
Syntheses
Ethyl-4-methyl-2-amino-5-acetylthiophene-3-carboxylate (1). – A mixture of acetylacetone
(0.01 mol), ethyl cyanoacetate (0.01 mol), sulfur (0.01 mol) and diethylamine (0.01 mol)
was heated at 70 C under stirring in absolute ethanol (20 mL) for 4 h, then the mixture
was left for 24 h at 0 C. The solid formed was collected by filtration, washed with etha-
nol (20 mL), dried and crystallized from absolute ethanol.
5-Acetyl-2-amino-4-methylthiophene-3-carbohydrazide (2). – A suspension of dry com-
pound 1 (0.01 mol) and hydrazine hydrate (5 mL) and (30 mL) absolute ethanol was stirred
under gentle reflux. The solid dissolved within 10 min with copious evolution of hydro-
gen sulfide to form a clear solution. After 30 min, the solid product started separating
out; heating was continued for 8 h. The reaction mixture was then allowed to cool to




none (3b). – Amixture of compound 2 (0.01 mol) and 2,4-diketone, namely, pentan-2,4-dione
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or 3-chloropentan-2,4-dione (0.01 mol) in absolute ethanol (30 mL), was stirred under re-
flux for 12 h. The reaction mixture was allowed to cool to 0 °C for 24 h, the solid precipi-
tate was filtered off, dried and crystallized from ethanol to produce 3a or 3b in high yields.
1-(4-Methyl-2-amino-5-acetylthiophene-3-carbonyl)pyrazolidine-3,5-dione (4). – A solution
of compound 2 (0.01 mol) and freshly distilled diethylmalonate (0.01 mol) in sodium
ethoxide was heated under reflux with stirring for 5 h. The solvent was evaporated un-
der reduced pressure and the crude product was acidified with 10 % hydrochloric acid.
The solid formed was filtered off, washed with cold water, and crystallized from etha-
nol.
(Z)-N’-(4-methyl-2-amino-5-acetylthiophene-3-carbonyl) formohydrazonic acid (5a). – A mix-
ture of compound 2 (0.01 mol) and formic acid (10 mL) was heated under reflux for 6 h.
The reaction mixture was allowed to cool to room temperature and poured onto water
(100 mL). The solid formed was collected by filtration, dried, and crystallized from ben-
zene.
(Z)-ethyl-N’-4-methyl-2-amino-5-acetylthiophene-3-carbonylformo hydrazonate (5b). – Amix-
ture of compound 2 (0.01 mol) and triethylorthoformate (20 mL) was heated under re-
flux with stirring for 2 h. The reaction mixture was filtered hot and the filtrate was left to
cool to room temperature. The solid formed was filtered off, dried and crystallized from
ethanol.
Synthesis of 1-(5-amino-3-methyl-4-(1,3,4-oxadiazol-2-yl) thiophen-2-yl) ethanone (6a) and
1-(5-amino-3-methyl-4-(1,3,4-oxathiadiazol-2-yl) thiophen-2-yl) ethanone (6b). – A mixture of
compounds 5a or 5b (0.005 mol) and phosphorus pentoxide (2 g) or phosphorus pen-
tasulfide (4 g) in dry xylene (30 mL) was heated under reflux for 6–12 h. The solid sepa-
rated upon cooling was filtered off, crystallized from ethanol to produce 6a and 6b, re-
spectively.
Ethyl-2-acetamido-4-methyl-5-acetylthiophene-3-carboxylate (7). – Amixture of compound
1 (0.01 mol) and acetic anhydride (30 mL) was heated under reflux for 3 h. The reaction
mixture was allowed to cool to room temperature and the solid formed was collected by
filtration, dried, and crystallized from ethanol.
6-Acetyl-3-amino-2,5-dimethylthieno[2,3-d]pyrimidin-4(3H)-one (8). – A mixture of 7
(0.01 mol) and hydrazine hydrate (10 mL) in ethanol (30 mL) was heated under reflux
for 2 h. The reaction mixture was allowed to cool to room temperature and poured into
water (100 mL). The solid formed was collected by filtration, dried and crystallized from
ethanol as yellow powder.
Ethyl-4-methyl-5-acetyl-2-(methylthiocarbonothioylamino) thiophene-3-carboxylate (9). –
To a vigorously stirred solution of 1 (0.02 mol) in dimethylsulfoxide DMSO (10 mL) at
room temperature, carbon disulfide (0.026 mol) and aqueous sodium hydroxide were added
simultaneously over 30 min; stirring was continued for further 30 min. Dimethylsulfate
(0.02 mol) was added dropwise to the reaction mixture under stirring at 5–10 °C. It was
stirred for another 2 h and poured into ice-water. The solid obtained was filtered off,
dried and recrystallized from ethanol.
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5-Methyl-3-amino-2-mercapto-6-acetylthieno[2,3-d]pyrimidin-4(3H)-one (10). – Method A:
A solution of 9 (0.01 mol) in ethanol (30 mL) and hydrazine hydrate (0.01 mol) was ad-
ded and refluxed on a water bath until the methyl mercaptan evolution ceased after 8 h.
After cooling, the solid obtained was filtered off, dried and recrystallized from ethanol/
acetone mixture. Method B: A solution of 2 (0.01 mol) in ethanol (30 mL) and aqueous
potassium hydroxide (0.01 mol) was refluxed for 30 min. After cooling to room tempera-
ture, carbon disulfide (1 mL) was added, refluxed for 2-3 hours and poured into ice-wa-
ter. The solid obtained was filtered off, dried and recrystallized from ethanol.
Ethyl-4-methyl-5-acetyl-2-thioureidothiophene-3-carboxylate (11). – A mixture of 1 (0.01
mol) and 10 % HCl (10 mL) was refluxed with potassium thiocyanate (0.015 mol) for 4 h.
The reaction mixture was allowed to cool to room temperature. The solid formed was
collected by filtration, washed with water, dried and crystallized from dioxane.
5-Methyl-6-acetyl-2-thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one (12). – A solu-
tion of 11 (0.01 mol) in ethanolic sodium ethoxide (0.23 g of sodium metal in 30 mL etha-
nol) was stirred under reflux for 6 h. After cooling, the reaction mixture was neutralized
with cool 10 % HCl and the solid formed was collected by filtration, washed with water,
dried and then crystallized from dimethylformamide.
Pharmacological screening
Ehrlich cells. – Ehrlich cells (Ehrlich ascites carcinoma, EAC) were derived from as-
cetic fluid from diseased mice (the cells were purchased from the National Cancer insti-
tute, Cairo, Egypt).
Antioxidant activity screening via erythrocyte hemolysis. – The blood was obtained
from rats by cardiac puncture and collected in heparinized tubes. Erythrocytes were se-
parated from plasma and the buffy coat was washed three times with 10 volumes of 0.15
mol L–1 NaCl. During the last wash, the erythrocytes were centrifuged at 2500 rpm for
10 min to obtain a constantly packed cell preparation. Erythrocyte hemolysis was medi-
ated by peroxyl radicals in this assay system (17). A 10 % suspension of erythrocytes in
phosphate buffered saline pH 7.4 (PBS) was added to the same volume of 200 mmol L–1
AAPH solution in PBS containing samples to be tested (50 mL of 2 mmol L–1 solution).
The reaction mixture was shaken gently while being incubated at 37 °C for 2 h. The reac-
tion mixture was then removed, diluted with eight volumes of PBS and centrifuged at
1500´g for 10 min. The absorbance of the supernatant was read at 540 nm. Similarly, the
reaction mixture was treated with 8 volumes of distilled water to achieve complete he-
molysis, and the absorbance of the supernatant obtained after centrifugation was mea-
sured at 540 nm. The data for hemolysis percentage was expressed as mean ± standard
deviation. L-ascorbic acid was used as a positive control.
Antioxidant activity screening via ABTS method. – For each of the investigated com-
pounds, 2 mL of ABTS solution (60 mmol L–1) was added to 3 mL MnO2 solution (g = 25
mg mL–1), all prepared in aqueous phosphate buffer (pH 7, 0.1 mol L–1). The mixture
was shaken, centrifuged, filtered and the absorbance of the resulting green-blue solution
(ABTS radical solution) at 734 nm was adjusted to approx. 0.5. Then, 50 mL of 2 mmol
L–1) solution of the test compound in spectroscopic grade MeOH/phosphate buffer (1:1)
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was added. The absorbance was measured and the reduction in color intensity was ex-
pressed as inhibition percentage. L-ascorbic acid was used as standard antioxidant (posi-
tive control). Blank sample was run without ABTS and using MeOH/phosphate buffer
(1:1) instead of a sample. Negative control was run with ABTS and MeOH/phosphate
buffer (1:1) instead of test compound (18–20).
Bleomycin-dependent DNA damage. – The assay was done according to Aeschlach (21)
with minor modifications. The reaction mixture (0.5 mL) contained calf thymus DNA
(0.5 mg mL–1), bleomycin sulfate (0.05 mg mL–1), MgCl2 (5 mmol L–1), FeCl3 (50 mmol
L–1) and the sample to be tested (50 mL of 2 mmol L–1 solution). L-ascorbic acid was used
as a positive control. The mixture was incubated at 37 °C for 1 h. The reaction was termi-
nated by addition 0.05 mL EDTA (0.1 mol L–1). The color was developed by adding 0.5
mL TBA (1 %, m/V) and 0.5 mL HCl (25 %, V/V) followed by heating at 37 °C for 15
min. After centrifugation, the extent of DNA damage was measured by the increase in
absorbance at 532 nm.
Antitumor activity using Ehrlich ascites in vitro assay. – Tested compounds were pre-
pared in a concentration of 25 mg mL–1 in DMSO. Ascites fluid from the peritoneal cavi-
ty of a diseased mouse (containing Ehrlich cells) was aseptically aspirated. The cells
were grown partly floating and partly attached in a suspension culture in RPMI 1640
medium, supplemented with 10 % fetal bovine serum. They were maintained at 37 °C in
a humidified atmosphere with 5 % CO2 for 2 h. The viability of the cells was determined
by microscopical examination using a hemocytometer and using trypan blue stain (stains
only dead cells) (22).
RESULTS AND DISCUSSION
Chemistry
First, aminothiophene (1) was prepared by the reaction of acetylacetone with ethyl-
cyanoacetate and sulfur in the presence of diethylamine following the Gewald proce-
dure (23). 1H NMR spectrum of 1 showed, beside the two signals of ester moiety, a new
broad singlet at d 6.66 ppm characteristic of the amino group. Moreover, the mass spec-
tra showed an ion peak m/z 227 [M+], which was in accord with the calculated molecu-
lar mass for C10H13NOS.
Hydrazide 2 was achieved after refluxing compound 1 with hydrazine hydrate in
ethanol. 1H NMR spectrum of 2 showed the absence of the two signals of ester moiety
detected in parent 1 along with other protons at their expected locations.
Hydrazide 2 reacted with 2,4-diketones, namely, pentane-2,4-dione or 3-chloropen-
tane-2,4-dione to afford 3a and 3b, respectively. The 1H NMR spectrum of 3a revealed
new signals at d 2.10 ppm assignable to 2 CH3 groups, d 7.96 ppm for pyrazole proton
and d 12.51 ppm for NH2 (as D2O exchangeable).
Also, hydrazide 2 reacted with diethylmalonate affording pyrazolidine-3,5-dione
derivative 4. The 1H NMR spectrum showed the absence of the hydrazo signal and the
presence of new signals at d 2.78 ppm for CH2 group and d 12.32 ppm corresponding to
(as a D2O exchangeable NH proton) along with other protons detected in parent 4.
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Treatment of 2 with formic acid or triethylorthoformate afforded 5a and 5b, respec-
tively, in fairly good yields. 1H NMR spectrum of 5a showed signals at d 8.44 ppm for
CH proton, and d 11.55 ppm (as a D2O exchangeable OH proton), while the 1H NMR
spectrum of 5b showed new signals at d 1.31, 4.32 ppm for CH2CH3 moiety and d 6.67
ppm for CH proton.
Moreover, compounds 5a and 5b undergo cyclization when treated with P2O5 and
P2S5, to yield thienyloxadiazole (6a) and thienylthiadiazole (6b) derivatives, respectively.
The 1H NMR spectrum of 6a and 6b showed signals at d 7.12 ppm characteristic of the
oxadiazole proton of 6a and d 7.85 ppm for thiadiazole proton of 6b beside the other ex-
pected signals characteristic of methyl, acetyl and amino groups.
Hydrazide 2 reacted with carbon disulphide in ethanolic potassium hydroxide to af-
ford thienopyrimidinone derivative (10). 1H NMR spectrum showed signals at d 6.12 ppm
for NH2 and d 7.44 ppm for NH proton (as D2O exchangeable) beside the signals charac-
teristic of acetyl and methyl groups; moreover, the mass spectrum revealed an ion peak
at m/z 255 [M+], which was in accord with the calculated molecular mass C9H9N3O2S2
(Scheme 1).
Compound 1, when treated with acetic anhydride, afforded 2-thienylacetamide de-
rivative (7). Moreover, when compound 7 was allowed to react with hydrazine hydrate,
it yielded aminothienopyrimidinone derivative (8). 1H NMR of 8 revealed signals at d
1.97 ppm for CH3 and 7.33 ppm (D2O exchangeable NH2 protons) with a lack of peaks
attributed to the ester protons detected in the parent compound 7.
When compound 1 was stirred with a mixture of carbon disulphide, sodium hydro-
xide in dimethylsulphoxide and dimethylsulphate, according to the Alagarsamy proce-
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dure (24), it afforded 9. 1H NMR spectrum of 9 showed the absence of the amino signal
and appearance of new signals at d 3.85 ppm for SCH3 and d 11.72 ppm (as a D2O ex-
changeable NH proton). It is worth mentioning that compound 9 cyclized with hydra-
zine hydrate to yield 10.
Finally, the reaction of compound 1 with potassium thiocyanate afforded the forma-
tion of 2-thioureidothiophene derivative (11). Moreover, when compound 11 was reflu-
xed in sodium ethoxide, it underwent self-cyclization to yield 2-thioxothienopyrimidi-
317
A. A. Abu-Hashem et al.: Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives
as antioxidant and antitumor agents, Acta Pharm. 60 (2010) 311–323.
Table I. Physical and analytical data of newly synthesized compounds
Compd.
No.













































































































































none derivative (12). The 1H NMR of 12 revealed signals at d 11.90, 12.29 ppm (as D2O
exchangeable 2 NH protons) with a lack of peaks attributed to the ester protons detected
in the parent compound 11 (Scheme 2).
Antioxidant activity
All compounds were tested for antioxidant activity as reflected in the ability to in-
hibit lipid peroxidation in rat brain and kidney homogenates and the rate of erythrocyte
hemolysis. Pro-oxidant activities of the formed compounds were assayed via their ef-
fects on bleomycin-induced DNA damage. Compounds 10 and 12 manifested potent
antioxidative activity in the lipid peroxidation assay but no inhibitory activity in the
hemolysis assay. On the other hand, compounds 3a, 4, 5a, 5b, 6a, 6b, 8, 10 and 12 exhib-
ited significant antioxidant activity and protected the DNA from damage (Table III).
Antitumor activity using the in vitro Ehrlich used ascites assay
The newly synthesized compounds were screened for their antitumor activity. Via-
bility of the cells used in control experiments exceeded 95 %. Compound 6a proved to
have the highest cytotoxic activity (83.1 %) followed by compounds 8, 10, 12 (79.9–77.2 %)
and 11 (67.9 %). The other tested compounds showed very weak activity (45.1–4.9 %)
(Table IV).
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2.10 (s, 6H, 2 CH3), 2.23 (s, 3H, CH3), 2.57 (s, 3H,
CO CH3), 7.96 (s, 1H, pyrazole proton), 12.51
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2.24 (s, 3H, CH3), 2.58 (s, 3H, COCH3), 2.78 (s,
2H, CH2), 9.35 (br.s, 2H, NH2, D2O exchangeable),






2.25 (s, 3H, CH3), 2.59 (s, 3H, COCH3), 8.44 (s,
1H, azomethine CH proton), 8.59 (br.s, 2H, NH2,
D2O exchangeable), 11.31 (s, 1H, NH, D2O ex-






1.31 (t, 3H, CH3), 2.26 (s, 3H, CH3), 2.60 (s, 3H,
COCH3), 4.32 (q, 2H, CH2), 6.67 (s, 1H, azome-
thine CH proton), 8.49 (br.s, 2H, NH2, D2O ex-






2.24 (s, 3H, CH3), 2.58 (s, 3H, COCH3), 7.12







2.27 (s, 3H, CH3), 2.60 (s, 3H, COCH3), 7.85
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COCH3), 2.59 (s, 3H, COCH3), 4.31 (q, 2H, CH2),






1.97 (s,3H, CH3), 2.23 (s, 3H, CH3), 2.58 (s, 3H,






1.28 (t, 3H, CH3), 2.25 (s, 3H, CH3), 2.58 (s, 3H,
COCH3), 3.85 (s, 3H, SCH3) 4.28 (q, 2H, CH2),






2.10 (s, 3H, CH3), 3.21 (s, 3H, COCH3), 6.12 (br.s,








1.29 (t, 3H, CH3), 2.24 (s, 3H, CH3), 2.59 (s, 3H,
COCH3), 4.32 (q, 2H, CH2), 6.84 (br.s, 2H, NH2, D2O






2.23 (s, 3H, CH3), 2.95 (s, 3H, COCH3), 11.90
(s, 1H, NH, D2O exchangeable), 12.29 (s, 1H, NH,
D2O exchangeable)
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a For testing 50 mL of 2 mmol L–1 solution in 1 mL methanol/phosphate buffer (1:1, V/V) was used.
Table IV. Ehrlich in vitro assay

















a 1 mg mL–1 in DMSO/RPMI-1640 (1:10)
b 25 mg mL–1 in DMSO/RPMI-1640 (1:10)
CONCLUSIONS
In summary, an interesting thiophene derivatives with substituted diazole, thiadia-
zole, pyrazole and pyrimidine moieties were synthesized and evaluated for their antiox-
idant and antitumor activities.
i) Novel thiophene derivatives wit substituted diazole, thiadiazole, pyrazole and
pyrimidine moieties possess a potential as antioxidant and antitum agents.
ii) Thienopyrimidinone derivatives were found to be of high antioxidant activity,
while thienoxathiazol and thienoxadiazole showed moderate activity compared
to thienopyrazole derivatives.
iii) Thienoxadiazole showed the highest cytotoxic activity, higher than thienopyri-
midinone and thienylthiourea derivatives.
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S A @ E T A K
Dizajniranje i sinteza novih derivata tiofenkarbohidrazida, tienopirazola i
tienopirimidina s antioksidativnim i antitumorskim djelovanjem
AMEEN ALI ABU-HASHEM, MOHAMED FATHY EL-SHEHRY i FARID ABD-ELRAHEEM BADRIA
Etilni ester 2-amino-5-acetil-4-metil-tiofen-3-karboksilne kiseline (1) i 5-acetil-2-amino-4-
-metiltiofen-3-karbohidrazid (2) sintetizirani su i upotrebljeni kao reaktanti u sintezi novih
spojeva 1-(5-amino-4-(3,5-dimetil-1H-pirazol-1-karbonil)-3-metiltiofen-2-il) etanona (3a), 1-(5-
-amino-4-(4-klor-3,5-dimetil-1H-pirazol-1-karbonil)-3-metiltiofen-2-il) etanona (3b), 1-(4-metil-
-2-amino-5-acetiltiofen-3-karbonil) pirazolidin-3,5-diona (4), (Z)-N’-(4-metil-2-amino-5-acetil-
tiofen-3-karbonil) formohidrazonske kiseline (5a), (Z)-etil-N’-(4-metil-2-amino-5-acetiltiofen-3-
karbonilformo hidrazonata (5b), 6-acetil-3-amino-2,5-dimetiltieno2,3-dpirimidin-4(3H)-one (8),
5-metil-3-amino-2-merkapto-6-acetiltieno2,3-dpirimidin-4(3H)-ona (10) i 5-metil-6-acetil-2-tio-
kso-2,3-dihidrotieno2,3-dpirimidin-4(1H)-ona (12) kao potencijalnih antioksidansa i citostatika.
Farmakolo{ka ispitivanja ukazuju na to da spojevi 6a, 6b, 8, 10 i 12 imaju zna~ajno antitu-
morsko i antioksidativno djelovanje.
Klju~ne rije~i: tienopirazol, tieno[2,3-d]pirimidini, tiofenkarbohidrazid, antioksidativno djelovanje,
bleomicin-ovisno DNA o{te}enje, antitumorsko djelovanje
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